High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes

Giorgio Bogani, Francesco Sopracordevole, Violante Di Donato, Andrea Ciavattini, Alessandro Ghelardi, Salvatore Lopez, Tommaso Simoncini, Francesco Plotti, Jvan Casarin, Maurizio Serati, Ciro Pinelli, Gaetano Valenti, Alice Bergamini, Barbara Gardella, Andrea Dell'acqua, Ermelinda Monti, Paolo Vercellini, Margherita Fischetti, Giovanni D'ippolito, Lorenzo AguzzoliVincenzo D. Mandato, Paola Carunchio, Gabriele Carlinfante, Luca Giannella, Cono Scaffa, Francesca Falcone, Chiara Borghi, Antonino Ditto, Mario Malzoni, Andrea Giannini, Maria Giovanna Salerno, Viola Liberale, Biagio Contino, Cristina Donfrancesco, Michele Desiato, Anna Myriam Perrone, Giulia Dondi, Pierandrea De Iaco, Valentina Chiappa, Simone Ferrero, Giuseppe Sarpietro, Maria G. Matarazzo, Antonio Cianci, Sara Bosio, Simona Ruisi, Rocco Guerrisi, Claudia Brusadelli, Lavinia Mosca, Antonio Simone Lagana’, Raffaele Tinelli, Mauro Signorelli, Rosa De Vincenzo, Gian Franco Zannoni, Gabriella Ferrandina, Sara Lovati, Marco Petrillo, Salvatore Dessole, Annunziata Carlea, Fulvio Zullo, Roberto Angioli, Stefano Greggi, Arsenio Spinillo, Fabio Ghezzi, Nicola Colacurci, Ludovico Muzii, Pierluigi Benedetti Panici, Giovanni Scambia, Francesco Raspagliesi

Research output: Contribution to journalArticlepeer-review

Abstract

Objective: To evaluate the outcomes of high-risk (HR) HPV-positive and -negative women affected by high-grade cervical dysplasia. Methods: This is a retrospective multi-institutional study. Medical records of consecutive patients with high-grade cervical dysplasia undergoing conization between 2010 and 2014 were retrieved. All patients included had at least 5 years of follow-up. A propensity-score matching was adopted in order to reduce the presence of confounding factors between groups. Kaplan-Meir and Cox hazard models were used to estimate 5-year outcomes. Results: Overall, data of 2966 women, affected by high-grade cervical dysplasia were reviewed. The study population included 1478 (85%) and 260 (15%) women affected by HR-HPV-positive and HR-HPV-negative high-grade cervical dysplasia. The prevalence of CIN2 and CIN3 among the HR-HPV-positive and -negative cohort was similar (p = 0.315). Patients with HR-HPV-positive high-grade cervical dysplasia were at higher risk of 5-year recurrence (after primary conization) that HR-HPV-negative patients (p < 0.001, log-rank test). Via multivariate analysis, HR-HPV-negative women were at low risk of recurrence (HR: 1.69 (95%CI: 1.05, 4.80); p = 0.018, Cox Hazard model). A propensity-score matched comparison was carried out in order to reduce biases that are related to the retrospective study design. In comparison to HR-HPV-negative patients, thosewith HR-HPV-positive CIN3 was associate with a 8-fold increase in the risk of recurrence (p < 0.001, log-rank test). Conclusions: HR-HPV-negative high-grade cervical dysplasia is not uncommon, accounting for 15% of our study population. Those patients experience more favorable outcomes than patients with documented HR-HPV infection(s). Further prospective studies are needed to corroborate our data.

Original languageEnglish
JournalGynecologic Oncology
DOIs
Publication statusAccepted/In press - 2021

Keywords

  • CIN
  • Conization
  • HPV
  • Negative
  • Positive

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynaecology

Fingerprint Dive into the research topics of 'High-risk HPV-positive and -negative high-grade cervical dysplasia: Analysis of 5-year outcomes'. Together they form a unique fingerprint.

Cite this